Literature DB >> 22340510

Serum bilirubin and lipoprotein-a: how are these associated with whole blood viscosity?

E U Nwose1, R S Richards, P Bwititi, E Butkowski.   

Abstract

BACKGROUND: It has been demonstrated that oxidative stress can induce red blood cell rigidity and haemolysis, which in turn can cause hyperviscosity and hyperbilirubinaemia, respectively. However, haemolysis may be associated with a low level of haemoglobin, which reduces whole blood viscosity (WBV). Bilirubin can behave as antioxidant or oxidant, and one uncharted course for diagnostic pathology is how or whether bilirubinaemia and viscosity are associated. Further, oxidative stress is now being assessed using lipoprotein-a (Lp(a)), among other things but whether it is associated with blood viscosity has not been established. AIM: This study investigates the association and correlation of haemoglobin level and WBV with serum Lp(a) and bilirubin levels in a general population of patients.
MATERIALS AND METHODS: Sixty-eight cases that were tested for Lp(a), concomitantly with full blood count and liver function, in our archived clinical pathology database were used in this study. WBV levels were determined using a validated formula. Multivariate and univariate analyses as well as correlation were performed.
RESULTS: WBV was found to be significantly associated with bilirubin (P<0.02), but not with Lp(a). Haemoglobin concentration was inversely correlated with Lp(a) (P<0.04), but not with bilirubinaemia.
CONCLUSION: This pilot study suggests that hyperbilirubinaemia and hyperviscosity are associated and positively correlated. Consideration of whether serum bilirubin (as an indirect index of oxidative stress) can be used in combination with WBV (as index of macrovascular effect of oxidative stress) to assess oxidative damage is recommended.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22340510      PMCID: PMC6837361          DOI: 10.1179/1351000211Y.0000000017

Source DB:  PubMed          Journal:  Redox Rep        ISSN: 1351-0002            Impact factor:   4.412


  32 in total

1.  Oxidative stress in families of type 1 diabetic patients.

Authors:  E Matteucci; O Giampietro
Journal:  Diabetes Care       Date:  2000-08       Impact factor: 19.112

2.  Rheology of human blood, near and at zero flow. Effects of temperature and hematocrit level.

Authors:  E W MERRILL; E R GILLILAND; G COKELET; H SHIN; A BRITTEN; R E WELLS
Journal:  Biophys J       Date:  1963-05       Impact factor: 4.033

3.  Formation of photoproducts and cytotoxicity of bilirubin irradiated with turquoise and blue phototherapy light.

Authors:  Ellen Bruzell Roll; Terje Christensen
Journal:  Acta Paediatr       Date:  2005-10       Impact factor: 2.299

4.  Use of a reference material proposed by the International Federation of Clinical Chemistry and Laboratory Medicine to evaluate analytical methods for the determination of plasma lipoprotein(a).

Authors:  S M Marcovina; J J Albers; A M Scanu; H Kennedy; F Giaculli; K Berg; R Couderc; F Dati; N Rifai; I Sakurabayashi; J R Tate; A Steinmetz
Journal:  Clin Chem       Date:  2000-12       Impact factor: 8.327

5.  Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies.

Authors:  J Danesh; R Collins; R Peto
Journal:  Circulation       Date:  2000-09-05       Impact factor: 29.690

6.  Increased lipoprotein (a) levels as an independent risk factor for venous thromboembolism.

Authors:  M von Depka; U Nowak-Göttl; R Eisert; C Dieterich; M Barthels; I Scharrer; A Ganser; S Ehrenforth
Journal:  Blood       Date:  2000-11-15       Impact factor: 22.113

7.  Role of plasma homocysteine and lipoprotein (a) in coronary artery disease.

Authors:  N A Barghash; S M Elewa; E A Hamdi; A A Barghash; R El Dine
Journal:  Br J Biomed Sci       Date:  2004       Impact factor: 3.829

8.  Erythroid apoptosis in idiopathic neonatal jaundice.

Authors:  Hasan Ozkan; Hale Oren; Mansur Tatli; Halil Ateş; Abdullah Kumral; Nuray Duman
Journal:  Pediatrics       Date:  2008-04-21       Impact factor: 7.124

9.  Racial (black-white) differences in serum lipoprotein (a) distribution and its relation to parental myocardial infarction in children. Bogalusa Heart Study.

Authors:  S R Srinivasan; G H Dahlen; R A Jarpa; L S Webber; G S Berenson
Journal:  Circulation       Date:  1991-07       Impact factor: 29.690

10.  Racial and Ethnic Variation in Lipoprotein (a) Levels among Asian Indian and Chinese Patients.

Authors:  Dipanjan Banerjee; Eric C Wong; Jessica Shin; Stephen P Fortmann; Latha Palaniappan
Journal:  J Lipids       Date:  2011-05-23
View more
  5 in total

1.  Newborn screening for autism: in search of candidate biomarkers.

Authors:  Gerald J Mizejewski; Barbara Lindau-Shepard; Kenneth A Pass
Journal:  Biomark Med       Date:  2013-04       Impact factor: 2.851

Review 2.  Changes in the Blood Viscosity in Patients With SARS-CoV-2 Infection.

Authors:  Hayder M Al-Kuraishy; Ali I Al-Gareeb; Sadiq M Al-Hamash; Simona Cavalu; Maisra M El-Bouseary; Fatma I Sonbol; Gaber El-Saber Batiha
Journal:  Front Med (Lausanne)       Date:  2022-06-17

Review 3.  Hyperviscosity syndrome in COVID-19 and related vaccines: exploring of uncertainties.

Authors:  Hayder M Al-Kuraishy; Ali I Al-Gareeb; Maisra M El-Bouseary; Fatma I Sonbol; Gaber El-Saber Batiha
Journal:  Clin Exp Med       Date:  2022-05-24       Impact factor: 5.057

4.  COVID-19 vaccine, immune thrombotic thrombocytopenia, jaundice, hyperviscosity: concern on cases with underlying liver problem.

Authors:  Pathum Sookaromdee; Viroj Wiwanitkit
Journal:  Ann Hepatol       Date:  2021 Sep-Oct       Impact factor: 3.388

5.  Bilirubin as an indicator of cardiometabolic health: a cross-sectional analysis in the UK Biobank.

Authors:  Nazlisadat Seyed Khoei; Karl-Heinz Wagner; Anja M Sedlmeier; Marc J Gunter; Neil Murphy; Heinz Freisling
Journal:  Cardiovasc Diabetol       Date:  2022-04-18       Impact factor: 8.949

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.